Skip to main content
Premium Trial:

Request an Annual Quote

Sigma-Aldrich Settles IP-Infringement Suit With Enzo

NEW YORK (GenomeWeb News) – Sigma-Aldrich and Enzo Biochem have settled a patent-infringement suit Enzo filed four years ago against Sigma and six other life science companies, Sigma-Aldrich said today.
 
While the terms of the settlement were not disclosed, Sigma said the settlement “will not have a material adverse effect on the consolidated financial condition, results of operations, or liquidity.”
 
The US District Court judge overseeing the case last week approved the settlement, stipulation, and order to dismiss all claims and defenses.
 
As reported by GenomeWeb News, a US District Court in July settled the interpretations of eight patents at the heart of a 4-year-old lawsuit pitting Enzo against defendants GE Healthcare, Affymetrix, PerkinElmer, Sigma-Aldrich, Orchid Biosciences, Molecular Probes, and Roche.
 
Since it first filed the suits in 2002 and 2003, Enzo has alleged that the defendants, by selling its reagent kits improperly, infringe 15 claims of eight different patents. The parties participated in a Markman hearing to define the interpretations of those claims in July 2005.
 
In the order, handed down July 10, Judge John Sprizzo of the US District Court in the Southern District of New York ruled that Enzo could indeed proceed with its litigation against the seven biotech firms. However, Sprizzo rejected many of Enzo’s interpretations of the eight patents, causing both Enzo and one of its opponents to claim a victory.
 
Enzo issued a statement after the ruling arguing that “the ruling supports Enzo’s position that hundreds of defendants’ products infringe certain Enzo patents” and “opens the door for Enzo to not only pursue its patent infringement claims, but, as importantly, to also aggressively pursue its claims that defendants breached their contractual obligations to Enzo.”
 
Two days later Roche said that the judge ruled in its favor on key aspects of the suit. According to Roche, the judge adopted "virtually all" of the interpretations proposed by Roche and its co-parties relating to seven Enzo patents.

The Scan

Interfering With Invasive Mussels

The Chicago Tribune reports that researchers are studying whether RNA interference- or CRISPR-based approaches can combat invasive freshwater mussels.

Participation Analysis

A new study finds that women tend to participate less at scientific meetings but that some changes can lead to increased involvement, the Guardian reports.

Right Whales' Decline

A research study plans to use genetic analysis to gain insight into population decline among North American right whales, according to CBC.

Science Papers Tie Rare Mutations to Short Stature, Immunodeficiency; Present Single-Cell Transcriptomics Map

In Science this week: pair of mutations in one gene uncovered in brothers with short stature and immunodeficiency, and more.